Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(17%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_2
2
33%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Other(1)

Detailed Status

Completed2
Enrolling by invitation1
Active, not recruiting1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (33.3%)
Phase 31 (16.7%)
N/A3 (50.0%)

Trials by Status

enrolling_by_invitation117%
active_not_recruiting117%
not_yet_recruiting117%
completed233%
unknown117%

Recent Activity

1 active trials
Showing 5 of 6
enrolling_by_invitationnot_applicable

Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

NCT07564947
not_yet_recruitingphase_2

Neuroprotection of Memantine and Rosuvastatin

NCT07504198
completedphase_2

Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

NCT02763033
active_not_recruitingnot_applicable

Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment

NCT07486141
completednot_applicable

Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers

NCT05567653
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07564947Not Applicable

Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

Enrolling By Invitation
NCT07504198Phase 2

Neuroprotection of Memantine and Rosuvastatin

Not Yet Recruiting
NCT02763033Phase 2

Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

Completed
NCT07486141Not Applicable

Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment

Active Not Recruiting
NCT05567653Not Applicable

Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers

Completed
NCT02504060Phase 3

Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
6